These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30093304)

  • 41. How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation?
    Menees SB; Guentner A; Chey SW; Saad R; Chey WD
    Am J Gastroenterol; 2015 Nov; 110(11):1516-25. PubMed ID: 26054623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of proton pump inhibitors in primary care. Always right?].
    Ricart-Pena T; Lozano-Espinosa M; Martínez-Lerma E; Bueno-Macías S
    Semergen; 2015; 41(8):455-6. PubMed ID: 25681873
    [No Abstract]   [Full Text] [Related]  

  • 43. We Are Using Too Many PPIs, and We Need to Stop: A European Perspective.
    Lanas A
    Am J Gastroenterol; 2016 Aug; 111(8):1085-6. PubMed ID: 27166129
    [No Abstract]   [Full Text] [Related]  

  • 44. Overuse of proton pump inhibitors.
    Ksiądzyna D; Szeląg A; Paradowski L
    Pol Arch Med Wewn; 2015; 125(4):289-98. PubMed ID: 25790817
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
    Chan J; Hui RL; Szpakowski JL
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The rise and rise of proton pump inhibitor drugs: patients' perspectives.
    Boath EH; Blenkinsopp A
    Soc Sci Med; 1997 Nov; 45(10):1571-9. PubMed ID: 9351147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inappropriate use of proton pump inhibitors in a local setting.
    Chia CT; Lim WP; Vu CK
    Singapore Med J; 2014 Jul; 55(7):363-6. PubMed ID: 25091884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit.
    Joret-Descout P; Dauger S; Bellaiche M; Bourdon O; Prot-Labarthe S
    Int J Clin Pharm; 2017 Feb; 39(1):181-186. PubMed ID: 28093644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inadequate prescription of chronic consumption of proton pump inhibitors in a hospital in Mexico. Cross-sectional study.
    Sánchez-Cuén JA; Irineo-Cabrales AB; Bernal-Magaña G; Peraza-Garay Fde J
    Rev Esp Enferm Dig; 2013 Mar; 105(3):131-6. PubMed ID: 23735019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationalizing the use of PPIs: an unresolved matter.
    Ponce J; Esplugues JV
    Rev Esp Enferm Dig; 2013 Mar; 105(3):121-4. PubMed ID: 23735017
    [No Abstract]   [Full Text] [Related]  

  • 51. The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wards.
    van Vliet EP; Steyerberg EW; Otten HJ; Rudolphus A; Knoester PD; Hoogsteden HC; van Gelder T; Kuijpers PM; Siersema PD
    Aliment Pharmacol Ther; 2009 Jan; 29(2):213-21. PubMed ID: 19006542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deprescribing in a family health team: a study of chronic proton pump inhibitor use.
    Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK
    J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton Pump Inhibitors: What the Internist Needs to Know.
    Spechler SJ
    Med Clin North Am; 2019 Jan; 103(1):1-14. PubMed ID: 30466666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA; Levy BH
    Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
    Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
    BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Esomeprazole: a proton pump inhibitor.
    Vachhani R; Olds G; Velanovich V
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):15-27. PubMed ID: 19210109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.
    Farrell B; Pottie K; Thompson W; Boghossian T; Pizzola L; Rashid FJ; Rojas-Fernandez C; Walsh K; Welch V; Moayyedi P
    Can Fam Physician; 2017 May; 63(5):354-364. PubMed ID: 28500192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Increased prescribing of proton pump inhibitors in ambulatory care over the years 2005 - 2013].
    Hoffmann F; Glaeske G; Schmiemann G
    Z Gastroenterol; 2015 Feb; 53(2):95-100. PubMed ID: 25251751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.